Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study-Reference-Cited by-同舟云学术

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study

Published:2020-07-21 Issue:3 Volume:35 Page:871-875
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tondeur Sylvie,Paul Franciane,Riou Jérémie,Mansier Olivier,Ranta Dana,Le Clech Lenaïg^ORCID,Lippert Eric^ORCID,Tavitian Suzanne,Chaoui Driss,Mercier Mélanie,De Renzis Benoit,Cottin Laurane,Cassinat Bruno,Chrétien Jean-Marie,Ianotto Jean-Christophe,Allangba Olivier^ORCID,Marzac Christophe,Voillat Laurent,Boyer Françoise,Orvain Corentin,Hunault-Berger Mathilde,Girodon François,Kiladjian Jean-Jacques^ORCID,Ugo Valérie,Luque Paz Damien^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0991-x.pdf

Reference19 articles.

1. Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med. 2007;356:459–68.

2. Zoi K, Cross NCP. Genomics of myeloproliferative neoplasms. J Clin Oncol. 2017;35:947–54.

3. Wang YL, Vandris K, Jones A, Cross NCP, Christos P, Adriano F, et al. JAK2 mutations are present in all cases of polycythemia vera. Leukemia. 2008;22:1289–1289.

4. Grisouard J, Li S, Kubovcakova L, Rao TN, Meyer SC, Lundberg P, et al. JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis. Blood. 2016;128:839–51.

5. Yao H, Ma Y, Hong Z, Zhao L, Monaghan SA, Hu M-C, et al. Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm. Leukemia. 2017;31:2122–31.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving landscape of polycythemia vera therapies;Expert Opinion on Pharmacotherapy;2024-07-23

2. Relationship between amide ratio assessed by Fourier‐transform infrared spectroscopy: A biomarker candidate for polycythemia vera disease;Journal of Biophotonics;2024-07-08

3. Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.);Clinical Oncohematology;2024-07-01

4. Sensitivity evaluation of methods for screening JAK2 exon 12 mutations based on heteroduplex and HRM analysis;Oncohematology;2024-01-27

5. Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms;International Journal of Molecular Sciences;2023-08-21